Detalhe da pesquisa
1.
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.
N Engl J Med
; 367(25): 2385-95, 2012 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23252525
2.
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial.
Ann Rheum Dis
; 74(6): 1110-7, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24834925
3.
Genetic variation in UGT1A1 typical of Gilbert syndrome is associated with unconjugated hyperbilirubinemia in patients receiving tocilizumab.
Pharmacogenet Genomics
; 21(7): 365-74, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21412181
4.
A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.
Pulm Ther
; 5(2): 151-163, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32026407
5.
Safety, Resistance, and Efficacy Results from a Phase IIIb Study of Conventional- and Double-Dose Oseltamivir Regimens for Treatment of Influenza in Immunocompromised Patients.
Infect Dis Ther
; 8(4): 613-626, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31667696
6.
IL-6 pathway-driven investigation of response to IL-6 receptor inhibition in rheumatoid arthritis.
BMJ Open
; 3(8): e003199, 2013 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23959753